Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Gynecol Endocrinol ; 26(11): 819-26, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20486877

ABSTRACT

AIM: This study was designed to measure serum fibroblast growth factor 21 (FGF21) levels in patients with polycystic ovary syndrome (PCOS) and healthy subjects. METHODS: A total of 37 women were evaluated. Serum levels FGF21, glucose, lipid profile, hormones (follicle-stimulating hormone, luteinising hormone, oestradiol, testosterone, thyroid stimulating hormone, prolactin and insulin) were determined in 24 PCOS (15 subjects of PCOS BMI < 25 kg/m2, 9 subjects of PCOS BMI ≥ kg/m2) and 13 control group (BMI < 25 kg/m2). RESULTS: Serum FGF21 levels were higher in the PCOS group [99.5 (173.7) pg/ml] than in the control group [52.0 (88.0) pg/ml]. LH and T are significantly higher in PCOS cases (respectively; p < 0.05, p < 0.01). A positive correlation was found between FGF21 and luteinising hormone and testosterone (respectively; r = 0.43 p = 0.007, r = 0.38, p = 0.02). Multivariate discriminant analysis showed that BMI, triglyceride, HOMA-IR, fasting glucose with rise of FGF21 were found significant in PCOS. CONCLUSION: Our study indicates that FGF21 in cases with PCOS exhibit an increase along with the increase of BMI and also has a positive correlation with LH and T. Further studies are required to clarify the aetiology and effects of FGF21 in women with PCOS.


Subject(s)
Fibroblast Growth Factors/blood , Polycystic Ovary Syndrome/blood , Adult , Blood Glucose/analysis , Body Mass Index , Discriminant Analysis , Female , Humans , Insulin Resistance , Luteinizing Hormone/blood , Testosterone/blood , Triglycerides/blood , Young Adult
2.
Brain Dev ; 26(5): 283-6, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15165666

ABSTRACT

Excitatory amino acids, cytokines and nitric oxide (NO) have been studied in the etiology and pathogenesis of hypoxic ischemic encephalopathy (HIE) of the newborn. Vascular endothelial growth factor (VEGF) is a known mediator of angiogenesis and has been shown to induce vascular proliferation and permeability via NO-mediated mechanism during hypoxia. The objective of this study was to investigate the cerebrospinal fluid and serum VEGF and NO levels in different stages of HIE and the correlation between the two mediators. Cerebrospinal fluid (CSF) and serum samples of 19 newborns with HIE and 13 controls were obtained within the first 24 h of life and kept at -70 degrees C until the time of measurement. NO levels were determined by Sievers NOA by chemiluminescence method and VEGF levels were measured by the enzyme-linked immunosorbent assay double sandwich method. The NO levels in CSF were higher than the control and mild HIE group in newborns with moderate to severe HIE, and VEGF levels in CSF were higher in the mild HIE group compared to controls but similar in the moderate to severe HIE group compared to mild HIE and control patients. There was no difference between groups with regard to serum NO or VEGF levels, and no correlation was observed between NO and VEGF levels both in CSF and serum samples. Depending on the severity of the hypoxic insult the stimulus for NO production by VEGF may have variable effects on endothelial cells which may give rise to the current results.


Subject(s)
Hypoxia-Ischemia, Brain/blood , Hypoxia-Ischemia, Brain/cerebrospinal fluid , Nitric Oxide/blood , Nitric Oxide/cerebrospinal fluid , Vascular Endothelial Growth Factor A/blood , Vascular Endothelial Growth Factor A/cerebrospinal fluid , Apgar Score , Birth Weight , Enzyme-Linked Immunosorbent Assay , Fetal Distress/diagnosis , Fetal Distress/physiopathology , Humans , Hydrogen-Ion Concentration , Infant, Newborn , Luminescent Measurements , Positive-Pressure Respiration
SELECTION OF CITATIONS
SEARCH DETAIL
...